How it works is wild: Researchers extract a patients immune cells, splice the cells DNA to add a new gene that helps them recognize a specific threat, and then infuse them back into the body by the millions
doi: 10.1186/s12902-025-01996-z
This mechanism can interrupt the cycle of restrictive eating followed by uncontrolled consumption that characterizes binge episodes
There also have been sporadic warning letters (like this one from December 2025) citing the unlawful distribution of unapproved GLP-1 agonists, such as retatrutide, to compounders
All observations (#1, #102 and #3) are therefore already publicly accessible on MAST 68,159
If obesity is treated as a chronic biological condition rather than a short-term problem, GLP-1s begin to look less like a treatment and more like a sustained system patients may not easily exit